{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T03:50:51Z","timestamp":1788493851614,"version":"build-2803163510"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T00:00:00Z","timestamp":1748217600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T00:00:00Z","timestamp":1748217600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-03464-z","type":"journal-article","created":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T08:39:48Z","timestamp":1748248788000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Association of circulating levels of anti-CarP antibodies with disease activity, disability and radiological damage in rheumatoid arthritis patients: an open-label, observational study"],"prefix":"10.1038","volume":"15","author":[{"given":"Milica","family":"Markovic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corrado","family":"Campochiaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Branislava","family":"Glisic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milan","family":"Petronijevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gorica","family":"Ristic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Stanojevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danilo","family":"Vojvodic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Viapiana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Matucci-Cerinic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Dagna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,26]]},"reference":[{"key":"3464_CR1","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/S0140-6736(10)60826-4","volume":"376","author":"DL Scott","year":"2010","unstructured":"Scott, D. L., Wolfe, F. & Huizinga, T. W. Rheumatoid arthritis. Lancet 376, 1094\u20131108 (2010).","journal-title":"Lancet"},{"issue":"7","key":"3464_CR2","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.autrev.2016.03.003","volume":"15","author":"P Conigliaro","year":"2016","unstructured":"Conigliaro, P. et al. Autoantibodies in inflammatory arthritis. Autoimmun Rev. 15(7), 673\u2013683 (2016).","journal-title":"Autoimmun Rev."},{"key":"3464_CR3","doi-asserted-by":"crossref","unstructured":"Shi, J., Knevel, R., Suwannalai, P., van der Linden, M. P., Janssen, G. M., van Veelen, P. A. et al. Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage. Proc. Natl. Acad. Sci. USA. 2011;108(42):17372\u20137.","DOI":"10.1073\/pnas.1114465108"},{"issue":"4","key":"3464_CR4","first-page":"437","volume":"39","author":"VFAM Derksen","year":"2017","unstructured":"Derksen, V. F. A. M., Huizinga, T. W. J. & van der Woude, D. The role of autoantibodies in the pathophysiology of rheumatoid arthritis. SeminImmunopathol. 39(4), 437\u2013446 (2017).","journal-title":"SeminImmunopathol."},{"key":"3464_CR5","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1093\/ndt\/15.8.1183","volume":"15","author":"A Wynckel","year":"2000","unstructured":"Wynckel, A. et al. Kinetics of carbamylated haemoglobin in acute renal failure. Nephrol Dial Transplant. 15, 1183\u20131188 (2000).","journal-title":"Nephrol Dial Transplant."},{"key":"3464_CR6","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1038\/nm1637","volume":"13","author":"Z Wang","year":"2007","unstructured":"Wang, Z. et al. Protein carbamylation links inflammation, smoking, uremia and atherogenesis. Nat Med. 13, 1176\u20131184 (2007).","journal-title":"Nat Med."},{"key":"3464_CR7","doi-asserted-by":"publisher","first-page":"6882","DOI":"10.4049\/jimmunol.1000075","volume":"184","author":"P Mydel","year":"2010","unstructured":"Mydel, P. et al. Carbamylation-dependent activation of T cells: A novel mechanism in the pathogenesis of autoimmune arthritis. J Immunol. 184, 6882\u20136890 (2010).","journal-title":"J Immunol."},{"issue":"1","key":"3464_CR8","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1186\/s13075-016-1173-0","volume":"18","author":"A Pecani","year":"2016","unstructured":"Pecani, A. et al. Prevalence, sensitivity and specificity of antibodies against carbamylated proteins in a monocentric cohort of patients with rheumatoid arthritis and other autoimmune rheumatic diseases. Arthritis Res Ther. 18(1), 276 (2016).","journal-title":"Arthritis Res Ther."},{"key":"3464_CR9","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1002\/art.37830","volume":"65","author":"J Shi","year":"2013","unstructured":"Shi, J. et al. Anti-carbamylated protein antibodies are present in arthralgia patients and predict the development of rheumatoid arthritis. ArthritisRheum. 65, 911\u2013915 (2013).","journal-title":"ArthritisRheum."},{"key":"3464_CR10","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1136\/annrheumdis-2012-201559","volume":"72","author":"J Shi","year":"2013","unstructured":"Shi, J. et al. Recognition of citrullinated and carbamylated proteins by human antibodies: Specificity, cross-reactivity and the \u201cAMC-Senshu\u201d method. Ann Rheum Dis 72, 148\u2013150 (2013).","journal-title":"Ann Rheum Dis"},{"key":"3464_CR11","doi-asserted-by":"publisher","first-page":"733511","DOI":"10.3389\/fimmu.2021.733511","volume":"12","author":"P Brevet","year":"2021","unstructured":"Brevet, P. et al. Anti-carbamylated fibrinogen antibodies might be associated with a specific rheumatoid phenotype and include a subset recognizing in vivo epitopes of its \u03b3 chain one of which is not cross reactive with anti-citrullinated protein antibodies. Front Immunol 12, 733511 (2021).","journal-title":"Front Immunol"},{"issue":"1\u20132","key":"3464_CR12","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s12026-014-8560-x","volume":"61","author":"A Yee","year":"2015","unstructured":"Yee, A. et al. Anti-CarP antibodies as promising marker to measure joint damage and disease activity in patients with rheumatoid arthritis. Immunol Res. 61(1\u20132), 24\u201330 (2015).","journal-title":"Immunol Res."},{"key":"3464_CR13","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13075-015-0536-2","volume":"17","author":"M Brink","year":"2015","unstructured":"Brink, M. et al. Anti-carbamylated protein antibodies in the presymptomatic phase of rheumatoid arthritis, their relationship with multiple anticitrulline peptide antibodies and association with radiological damage. Arthritis Res Ther. 17, 25 (2015).","journal-title":"Arthritis Res Ther."},{"key":"3464_CR14","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1136\/ard.2010.138461","volume":"69","author":"D Aletaha","year":"2010","unstructured":"Aletaha, D. et al. 2010 Rheumatoid arthritis classification criteris: An American College of Rheumatology\/European league against rheumatism collaborative initiative. Ann Rheum Dis 69, 1580\u20131588 (2010).","journal-title":"Ann Rheum Dis"},{"key":"3464_CR15","doi-asserted-by":"crossref","unstructured":"Prevoo, M. L., van Riel, P. L. et al. Validity and reliabilitiy of joint indices. A longitudinal study in patients with recent onset rheumatoid arthritis. Br. J. Rheumatol. 1993;32(7):589\u2013594.","DOI":"10.1093\/rheumatology\/32.7.589"},{"key":"3464_CR16","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1477-7525-1-20","volume":"1","author":"B Bruce","year":"2003","unstructured":"Bruce, B. & Fries, J. F. The Stanford Health Assessment Questionnaire: Dimensions and practical applications. Health Qual Life Outcomes. 1, 20 (2003).","journal-title":"Health Qual Life Outcomes."},{"key":"3464_CR17","doi-asserted-by":"publisher","first-page":"129","DOI":"10.2147\/OARRR.S163731","volume":"10","author":"D Iacono","year":"2018","unstructured":"Iacono, D. et al. Low mortality rate in Italian rheumatoid arthritis patients from a tertiary center: Putative implication of a low anti-carbamylated protein antibodies prevalence. Open Access Rheumatol. 10, 129\u2013134 (2018).","journal-title":"Open Access Rheumatol."},{"key":"3464_CR18","doi-asserted-by":"crossref","unstructured":"van der Helm-van Mil, A. H., Breedveld, F. C., Huizinga, T. W. Aspects of early arthritis. Definition of disease states in early arthritis: remission versus minimal disease activity. Arthritis Res. Ther. 2006;8:216.","DOI":"10.1186\/ar1983"},{"key":"3464_CR19","doi-asserted-by":"crossref","unstructured":"Humphreys, J. H., Warner, A., Chipping, J., Marshall, T., Lunt, M., Symmons, D. P., Verstappen, S. M. Mortality trends in patients with early rheumatoid arthritis over 20 years: Results from the Norfolk Arthritis Register. Arthritis Care Res. (Hoboken) 2014;66:1296\u2013301.","DOI":"10.1002\/acr.22296"},{"key":"3464_CR20","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1136\/ard.2003.017574","volume":"63","author":"L De Rycke","year":"2004","unstructured":"De Rycke, L. et al. Rheumatoid factor and anticitrullinated protein antibodies in rheumatoid arthritis: Diagnostic value, associations with radiological progression rate, and extra-articular manifestations. Ann Rheum Dis 63, 1587\u20131593 (2004).","journal-title":"Ann Rheum Dis"},{"key":"3464_CR21","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s00296-010-1671-3","volume":"32","author":"K Shidara","year":"2012","unstructured":"Shidara, K. et al. Anti-cyclic citrullinated peptide antibody predicts functional disability in patients with rheumatoid arthritis in a large prospective observational cohort in Japan. RheumatolInt 32, 361\u2013366 (2012).","journal-title":"RheumatolInt"},{"key":"3464_CR22","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1186\/s13075-014-0483-3","volume":"16","author":"JH Humphreys","year":"2014","unstructured":"Humphreys, J. H. et al. Rheumatoid factor and anti-citrullinated protein antibody positivity, but not level, are associated with increased mortality in patients with rheumatoid arthritis: results from two large independent cohorts. Arthritis Res Ther. 16, 483 (2014).","journal-title":"Arthritis Res Ther."},{"key":"3464_CR23","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1136\/annrheumdis-2013-204154","volume":"73","author":"J Shi","year":"2014","unstructured":"Shi, J. et al. Anti-carbamylated protein (anti-CarP) antibodies precede the onset of rheumatoid arthritis. Ann Rheum Dis 73, 780\u2013783 (2014).","journal-title":"Ann Rheum Dis"},{"key":"3464_CR24","doi-asserted-by":"publisher","first-page":"572","DOI":"10.3899\/jrheum.140767","volume":"42","author":"RW Gan","year":"2015","unstructured":"Gan, R. W. et al. Anti-carbamylated protein antibodies are present prior to rheumatoid arthritis and are associated with its future diagnosis. J Rheumatol 42, 572\u2013579 (2015).","journal-title":"J Rheumatol"},{"issue":"7","key":"3464_CR25","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.3390\/diagnostics12071661","volume":"12","author":"V Ricchiuti","year":"2022","unstructured":"Ricchiuti, V. et al. Anti-carbamylated protein (anti-CarP) antibodies in patients evaluated for suspected rheumatoid arthritis. Diagnostics (Basel). 12(7), 1661 (2022).","journal-title":"Diagnostics (Basel)."},{"issue":"7","key":"3464_CR26","doi-asserted-by":"publisher","first-page":"e0180144","DOI":"10.1371\/journal.pone.0180144","volume":"12","author":"L Vidal-Bralo","year":"2017","unstructured":"Vidal-Bralo, L. et al. Anti-carbamylated protein autoantibodies associated with mortality in Spanish rheumatoid arthritis patients. PLoS ONE 12(7), e0180144 (2017).","journal-title":"PLoS ONE"},{"issue":"1","key":"3464_CR27","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12891-021-04985-0","volume":"23","author":"S Oka","year":"2022","unstructured":"Oka, S. et al. Serum rheumatoid factor IgA, anti-citrullinated peptide antibodies with secretory components, and anti-carbamylated protein antibodies associate with interstitial lung disease in rheumatoid arthritis. BMC Musculoskelet Disord. 23(1), 46 (2022).","journal-title":"BMC Musculoskelet Disord."},{"key":"3464_CR28","doi-asserted-by":"crossref","unstructured":"Verheul, M. K., B\u00f6hringer, S., van Delft, M. A. M., Jones, J. D., Rigby, W. F. C., Gan, R. W. et al. Triple positivity for anti-citrullinated protein autoantibodies, rheumatoid factor, and anti-carbamylated protein antibodies conferring high specificity for rheumatoid arthritis: implications for very early identification of at-risk individuals. Arthritis Rheumatol. 2018;70(11):1721\u20131731.","DOI":"10.1002\/art.40562"},{"key":"3464_CR29","doi-asserted-by":"publisher","first-page":"e0161141","DOI":"10.1371\/journal.pone.0161141","volume":"11","author":"A Montes","year":"2016","unstructured":"Montes, A. et al. Anti-carbamylated protein antibodies as a reproducible independent type of rheumatoid arthritis autoantibodies. PLoS ONE 11, e0161141 (2016).","journal-title":"PLoS ONE"},{"key":"3464_CR30","doi-asserted-by":"crossref","unstructured":"Othman, M. A., Ghazali, W. S. W., Hamid, W. Z. W. A., Wong, K. K., Yahya, N. K. Anti-carbamylated protein antibodies in rheumatoid arthritis patients and their association with rheumatoid factor. Saudi Med. J. 2017;38(9):934\u2013941.","DOI":"10.15537\/smj.2017.9.20841"},{"issue":"1","key":"3464_CR31","doi-asserted-by":"publisher","first-page":"4","DOI":"10.5114\/reum.2017.66680","volume":"55","author":"S Kumar","year":"2017","unstructured":"Kumar, S., Pangtey, G., Gupta, R., Rehan, H. S. & Gupta, L. K. Assessment of anti-CarP antibodies, disease activity and quality of life in rheumatoid arthritis patients on conventional and biological disease-modifying antirheumatic drugs. Reumatologia 55(1), 4\u20139 (2017).","journal-title":"Reumatologia"},{"key":"3464_CR32","doi-asserted-by":"crossref","unstructured":"Humphreys, J. H., Verheul, M. K., Barton, A., MacGregor, A. J., Lunt, M., Toes, R. E. et al. Association of anti-carbamylated protein antibodies with long-term disability and increased disease activity in patients with early inflammatory arthritis: results from the Norfolk Arthritis Register. Lancet. 2015;385Suppl 1:S44.","DOI":"10.1016\/S0140-6736(15)60359-2"},{"issue":"10","key":"3464_CR33","first-page":"2683","volume":"38","author":"SA Elsayed","year":"2019","unstructured":"Elsayed, S. A., Esmail, M. A., Ali, R. M. & Mohafez, O. M. Diagnostic and prognostic value of anti-CarP antibodies in a sample of Egyptian rheumatoid arthritis patients. ClinRheumatol. 38(10), 2683\u20132689 (2019).","journal-title":"ClinRheumatol."},{"issue":"6","key":"3464_CR34","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1136\/jim-2019-001249","volume":"68","author":"B Zhang","year":"2020","unstructured":"Zhang, B. et al. Elevated levels of anti- carbamylated protein antibody in patients with rheumatoid arthritis: association with disease activity and bone destruction. J Investig Med. 68(6), 1186\u20131192 (2020).","journal-title":"J Investig Med."},{"key":"3464_CR35","doi-asserted-by":"crossref","unstructured":"Elsawy, N. A., Mohamed, R. A., Ghazala, R. A., Abdelshafy, M. A., Elnemr, R. Anti-carbamylated protein antibodies in premenopausal rheumatoid arthritis women: relation to disease activity and bone loss. Rheumatology (Oxford). 2020 Sep 30:keaa549.","DOI":"10.1093\/rheumatology\/keaa549"},{"key":"3464_CR36","doi-asserted-by":"publisher","first-page":"192","DOI":"10.3389\/fimmu.2015.00192","volume":"6","author":"GJ Pruijn","year":"2015","unstructured":"Pruijn, G. J. Citrullination and carbamylation in the pathophysiology of rheumatoid arthritis. Front Immunol. 6, 192 (2015).","journal-title":"Front Immunol."},{"key":"3464_CR37","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1136\/annrheumdis-2013-205109","volume":"73","author":"X Jiang","year":"2014","unstructured":"Jiang, X. et al. Anti-CarP antibodies in two large cohorts of patients with rheumatoid arthritis and their relationship to genetic risk factors, cigarette smoking and other autoantibodies. Ann Rheum Dis 73, 1761\u20131768 (2014).","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"3464_CR38","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1002\/art.39664","volume":"68","author":"H Koppejan","year":"2016","unstructured":"Koppejan, H. et al. Role of anti-carbamylated protein antibodies compared to anti-citrullinated protein antibodies in indigenous North Americans with rheumatoid arthritis, their first-degree relatives, and healthy controls. Arthritis Rheumatol. 68(9), 2090\u20132098 (2016).","journal-title":"Arthritis Rheumatol."},{"key":"3464_CR39","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1186\/s13075-016-1177-9","volume":"18","author":"TJ van Wesemael","year":"2016","unstructured":"van Wesemael, T. J. et al. Smoking is associated with the concurrent presence of multiple autoantibodies in rheumatoid arthritis rather than with anticitrullinated protein antibodies per se: A multicenter cohort study. Arthritis Res Ther 18, 285 (2016).","journal-title":"Arthritis Res Ther"},{"issue":"8","key":"3464_CR40","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1136\/annrheumdis-2016-209248","volume":"75","author":"MK Verheul","year":"2016","unstructured":"Verheul, M. K. et al. Anti-carbamylated protein antibodies: A specific hallmark for rheumatoid arthritis. Comparison to conditions known for enhanced carbamylation; renal failure, smoking and chronic inflammation. Ann Rheum Dis. 75(8), 1575\u20131576 (2016).","journal-title":"Ann Rheum Dis."},{"issue":"2","key":"3464_CR41","doi-asserted-by":"publisher","first-page":"R99","DOI":"10.1186\/ar4547","volume":"16","author":"WP Maksymowych","year":"2014","unstructured":"Maksymowych, W. P. et al. 14-3-3\u03b7 is a novel mediator associated with the pathogenesis of rheumatoid arthritis and joint damage. Arthritis Res Ther. 16(2), R99 (2014).","journal-title":"Arthritis Res Ther."},{"issue":"4","key":"3464_CR42","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1080\/14397595.2019.1637575","volume":"30","author":"N Hammam","year":"2020","unstructured":"Hammam, N., Salah, S., Kholef, E. F., Moussa, E. M. & Marotta, A. 14-3-3\u03b7 Protein in serum and synovial fluid correlates with radiographic damage and progression in a longitudinal evaluation of patients with established rheumatoid arthritis. Mod Rheumatol. 30(4), 664\u2013670 (2020).","journal-title":"Mod Rheumatol."},{"issue":"39","key":"3464_CR43","doi-asserted-by":"publisher","first-page":"6510","DOI":"10.2174\/0109298673295359240422115759","volume":"31","author":"A Kor","year":"2024","unstructured":"Kor, A. et al. Does eta protein differentiate rheumatoid arthritis from psoriatic arthritis?. Curr Med Chem. 31(39), 6510\u20136520 (2024).","journal-title":"Curr Med Chem."},{"key":"3464_CR44","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/1741-7015-12-49","volume":"12","author":"L \u0160enolt","year":"2014","unstructured":"\u0160enolt, L., Grassi, W. & Szodoray, P. Laboratory biomarkers or imaging in the diagnostics of rheumatoid arthritis?. BMC Med. 12, 49 (2014).","journal-title":"BMC Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-03464-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-03464-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-03464-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T08:39:50Z","timestamp":1748248790000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-03464-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,26]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3464"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-03464-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,26]]},"assertion":[{"value":"15 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18325"}}